Since we found in an exploratory analysis using LUAD and LUSC datasets that downregulated ZNF677 expression is associated with a shorter OS in a subgroup of NSCLC patients, also ZNF677 expression might be of potential prognostic impact. This evidence concerns the gene ZNF677 and non-small cell lung carcinoma.